Sun Pharmaceutical Industries Ltd.

NSE: SUNPHARMA | BSE: 524715 | ISIN: INE044A01036 | Industry: Pharmaceuticals
| Falling Comet
1664.9000 -2.60 (-0.16%)
NSE Jun 04, 2025 15:31 PM
Volume: 1.7M
 

logo
Sun Pharmaceutical Industries Ltd.
23 May 2024
1664.90
-0.16%
buy
by BOB Capital Markets Ltd.
Target: 1530
BOB Capital Markets Ltd.
SUNP missed consensus EBITDA estimate by 4% as higher R&D spend offset gross margin gains; higher other income & low tax aided PAT
 
Number of FII/FPI investors increased from 1310 to 1351 in Mar 2025 qtr.
More from Sun Pharmaceutical Industries Ltd.
Recommended
Market closes higher, TVS signs MoU with Kadam Mobility to deploy 500 electric 3-wheelers in FY26
Trendlyne Marketwatch | 04 Jun 2025, 03:56PM
Chart of the Week: Stocks and sectors with the highest dividend yields
The Baseline | 04 Jun 2025, 02:06PM
Change is hard, and some Indian pharma companies are embracing it better than others
| 09 Aug 2022